BG62259B1 - Гликогенови полизахариди и метод за тяхното получаване - Google Patents
Гликогенови полизахариди и метод за тяхното получаване Download PDFInfo
- Publication number
- BG62259B1 BG62259B1 BG99421A BG9942195A BG62259B1 BG 62259 B1 BG62259 B1 BG 62259B1 BG 99421 A BG99421 A BG 99421A BG 9942195 A BG9942195 A BG 9942195A BG 62259 B1 BG62259 B1 BG 62259B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- glycogen
- polysaccharide
- water
- carried out
- snell
- Prior art date
Links
- 229920002527 Glycogen Polymers 0.000 title claims abstract description 55
- 229940096919 glycogen Drugs 0.000 title claims abstract description 54
- 229920001282 polysaccharide Polymers 0.000 title claims description 34
- 239000005017 polysaccharide Substances 0.000 title claims description 33
- 150000004676 glycans Chemical class 0.000 title claims description 32
- 238000000034 method Methods 0.000 title claims description 26
- 238000002360 preparation method Methods 0.000 title description 5
- 235000000346 sugar Nutrition 0.000 claims abstract description 17
- 150000008163 sugars Chemical class 0.000 claims abstract description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 229920005989 resin Polymers 0.000 claims description 16
- 239000011347 resin Substances 0.000 claims description 16
- 125000002091 cationic group Chemical group 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 230000002378 acidificating effect Effects 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000002244 precipitate Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 8
- 235000019441 ethanol Nutrition 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 229910017464 nitrogen compound Inorganic materials 0.000 claims description 6
- 150000002830 nitrogen compounds Chemical class 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 229920001429 chelating resin Polymers 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 238000006386 neutralization reaction Methods 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims 2
- 230000009089 cytolysis Effects 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 125000005909 ethyl alcohol group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 210000001519 tissue Anatomy 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 241000287826 Gallus Species 0.000 description 5
- 241000237524 Mytilus Species 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 241000237536 Mytilus edulis Species 0.000 description 3
- 102000016611 Proteoglycans Human genes 0.000 description 3
- 108010067787 Proteoglycans Proteins 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000007696 Kjeldahl method Methods 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001523579 Ostrea Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- LBDSXVIYZYSRII-IGMARMGPSA-N alpha-particle Chemical compound [4He+2] LBDSXVIYZYSRII-IGMARMGPSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- -1 glucose polysaccharide Chemical class 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Sustainable Development (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI921927A IT1255488B (it) | 1992-08-04 | 1992-08-04 | Polisaccaridi del glicogeno |
| PCT/EP1993/002006 WO1994003502A1 (en) | 1992-08-04 | 1993-07-28 | Glycogen polysaccharides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG99421A BG99421A (en) | 1995-09-29 |
| BG62259B1 true BG62259B1 (bg) | 1999-06-30 |
Family
ID=11363836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG99421A BG62259B1 (bg) | 1992-08-04 | 1995-02-13 | Гликогенови полизахариди и метод за тяхното получаване |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US5597913A (it) |
| EP (1) | EP0654048B1 (it) |
| JP (1) | JP3204321B2 (it) |
| KR (1) | KR100277301B1 (it) |
| AT (1) | ATE148471T1 (it) |
| AU (1) | AU680200B2 (it) |
| BG (1) | BG62259B1 (it) |
| BR (1) | BR9306833A (it) |
| CA (1) | CA2141040C (it) |
| CZ (1) | CZ282276B6 (it) |
| DE (1) | DE69307897T2 (it) |
| DK (1) | DK0654048T3 (it) |
| ES (1) | ES2100552T3 (it) |
| FI (1) | FI104974B (it) |
| GE (1) | GEP20001941B (it) |
| GR (1) | GR3023249T3 (it) |
| HU (1) | HU213908B (it) |
| IT (1) | IT1255488B (it) |
| MX (1) | MX9304731A (it) |
| NO (1) | NO307788B1 (it) |
| NZ (1) | NZ254777A (it) |
| RO (1) | RO117970B1 (it) |
| RU (1) | RU2104287C1 (it) |
| SK (1) | SK280066B6 (it) |
| WO (1) | WO1994003502A1 (it) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1255488B (it) * | 1992-08-04 | 1995-11-06 | Angelini Francesco Ist Ricerca | Polisaccaridi del glicogeno |
| WO1999026636A1 (fr) * | 1997-11-24 | 1999-06-03 | Zhongming Zeng | Formulation pharmaceutique de stimulation de la croissance de bacilles gram positifs et d'augmentation de l'acidite du vagin et leur utilisation |
| IT1298758B1 (it) * | 1998-03-19 | 2000-02-02 | Angelini Ricerche Spa | Soluzione umettante e lubrificante per uso oftalmico |
| US6964949B2 (en) | 2000-05-24 | 2005-11-15 | Shanghai Jiao Da Onlly Co., Ltd. | Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof |
| TWI250166B (en) * | 2001-12-07 | 2006-03-01 | Bizen Chemical Co Ltd | Method of physicochemically producing glycogen and glycogen obtained by the same |
| US20050271746A1 (en) * | 2004-05-18 | 2005-12-08 | Abbott Chun L | Topical treatments for abnormal biological conditions and method of topically treating such conditions |
| AR069960A1 (es) | 2007-12-28 | 2010-03-03 | Acraf | Formulacion farmaceutica de liberacion controlada y procedimiento para su preparacion |
| US20100273736A1 (en) * | 2008-02-01 | 2010-10-28 | Aziende Chim. Riun. Ang. Franc. A.C.R.A.F. S.P.A. | Cosmetic composition comprising glycogen for skin application with velvet effect |
| SG171444A1 (en) * | 2009-01-23 | 2011-07-28 | Acraf | Controlled release pharmaceutical or food formulation and process for its preparation |
| JP5639649B2 (ja) | 2009-08-03 | 2014-12-10 | アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅ Ｃｈｉｍｉｃｈｅ Ｒｉｕｎｉｔｅ Ａｎｇｅｌｉｎｉ Ｆｒａｎｃｅｓｃｏ Ａ．Ｃ．Ｒ．Ａ．Ｆ．Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ | グリコーゲンを含む食品製剤 |
| JP2011037790A (ja) * | 2009-08-13 | 2011-02-24 | Central Res Inst Of Electric Power Ind | 肝機能亢進剤及び機能性食品 |
| RS58985B1 (sr) | 2012-03-15 | 2019-08-30 | Acraf | Katjonski polimeri na bazi glikogena |
| AR095937A1 (es) | 2013-04-05 | 2015-11-25 | Acraf | Potenciador de la solubilidad en agua a base de glucógeno |
| KR102214865B1 (ko) | 2013-04-26 | 2021-02-15 | 마이렉서스 바이오테크놀로지스 인코퍼레이티드 | 파이토글리코겐 나노입자와 이를 제조하는 방법 |
| AR108280A1 (es) | 2016-05-05 | 2018-08-08 | Acraf | Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo |
| WO2022000205A1 (zh) * | 2020-06-29 | 2022-01-06 | 肇庆大华农生物药品有限公司 | 一种禽流感疫苗佐剂及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3592168A (en) * | 1969-05-02 | 1971-07-13 | Offshore Sea Dev Corp | Method of raising bivalves in a controlled environment |
| FR2477416A1 (fr) * | 1980-03-10 | 1981-09-11 | Unicler | Utilisation de hansenula ou d'extraits de hansenula, comme medicament |
| JPS6427454A (en) * | 1987-07-22 | 1989-01-30 | Mizusawa Industrial Chem | Concentrated shellfishes and production thereof |
| IT1255488B (it) * | 1992-08-04 | 1995-11-06 | Angelini Francesco Ist Ricerca | Polisaccaridi del glicogeno |
-
1992
- 1992-08-04 IT ITMI921927A patent/IT1255488B/it active IP Right Grant
-
1993
- 1993-07-28 HU HU9500317A patent/HU213908B/hu unknown
- 1993-07-28 AU AU47034/93A patent/AU680200B2/en not_active Expired
- 1993-07-28 CZ CZ95254A patent/CZ282276B6/cs not_active IP Right Cessation
- 1993-07-28 KR KR1019950700391A patent/KR100277301B1/ko not_active Expired - Lifetime
- 1993-07-28 RO RO95-00184A patent/RO117970B1/ro unknown
- 1993-07-28 DK DK93917674.9T patent/DK0654048T3/da active
- 1993-07-28 CA CA002141040A patent/CA2141040C/en not_active Expired - Lifetime
- 1993-07-28 JP JP50497494A patent/JP3204321B2/ja not_active Expired - Fee Related
- 1993-07-28 AT AT93917674T patent/ATE148471T1/de active
- 1993-07-28 BR BR9306833A patent/BR9306833A/pt not_active IP Right Cessation
- 1993-07-28 NZ NZ254777A patent/NZ254777A/en not_active IP Right Cessation
- 1993-07-28 ES ES93917674T patent/ES2100552T3/es not_active Expired - Lifetime
- 1993-07-28 RU RU95106640A patent/RU2104287C1/ru active
- 1993-07-28 WO PCT/EP1993/002006 patent/WO1994003502A1/en not_active Ceased
- 1993-07-28 DE DE69307897T patent/DE69307897T2/de not_active Expired - Lifetime
- 1993-07-28 GE GEAP19932647A patent/GEP20001941B/en unknown
- 1993-07-28 EP EP93917674A patent/EP0654048B1/en not_active Expired - Lifetime
- 1993-07-28 SK SK114-95A patent/SK280066B6/sk not_active IP Right Cessation
- 1993-08-04 MX MX9304731A patent/MX9304731A/es active IP Right Grant
-
1995
- 1995-01-26 US US08/373,266 patent/US5597913A/en not_active Expired - Lifetime
- 1995-02-01 FI FI950436A patent/FI104974B/fi not_active IP Right Cessation
- 1995-02-03 NO NO950405A patent/NO307788B1/no not_active IP Right Cessation
- 1995-02-13 BG BG99421A patent/BG62259B1/bg unknown
-
1996
- 1996-10-21 US US08/736,036 patent/US5734045A/en not_active Expired - Lifetime
-
1997
- 1997-04-22 GR GR970400914T patent/GR3023249T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3204321B2 (ja) | グリコーゲン多糖類 | |
| Kay et al. | An improved preparation of sodium desoxyribonucleate | |
| Chambers et al. | Isolation of glycine betaine and proline betaine from human urine. Assessment of their role as osmoprotective agents for bacteria and the kidney. | |
| Fründ et al. | The quantitative analysis of solution-and CPMAS-C-13 NMR spectra of humic material | |
| CN106467577B (zh) | 一种牛肺依诺肝素钠及其制备方法与应用 | |
| Swann et al. | Determination of the hexosamine content of macro-molecules with manual and automated techniques using the p-dimethylaminobenzaldehyde reaction | |
| CA1297430C (en) | Process for obtaining chemically defined and reproducible polydeoxyribonucleotide | |
| CN118725035B (zh) | 一种海参活性多肽及其制备方法和应用 | |
| Berenson et al. | Connective tissue macromolecular changes in rats with experimentally induced diabetes and hyperinsulinism | |
| US4421746A (en) | Process for producing interferon inducers | |
| Brunngraber et al. | Isolation and determination of non‐diffusible sialofucohexosaminoglycans derived from brain glycoproteins and their anatomical distribution in bovine brain | |
| US5268366A (en) | Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient | |
| DE2701890A1 (de) | Alpha-amylase-inhibitor aus einem streptomyceten und verfahren zu seiner gewinnung | |
| CN117964790B (zh) | 盐地碱蓬多糖及其制备方法和应用 | |
| CN121699030B (zh) | 一种富集结合态唾液酸的抗病毒燕窝多糖活性组分、制备方法及其应用 | |
| RU2779914C1 (ru) | Способ получения днк-содержащего препарата для перорального применения и препарат, полученный этим способом | |
| CN118126207B (zh) | 一种甜菜多糖的制备方法及用途 | |
| SUZUKI | BIOCHEMICAL STUDIES ON CARBOHYDRATES LIX. Isolation of Pure Polysaccharide from Ovomucoid | |
| CN116784415A (zh) | 一种海藻蛋白的提纯包埋方法及应用 | |
| Stacey | V. Conjugated proteins (nucleo-and muco-proteins). Conjugated proteins | |
| TASHIRO et al. | INCREASE OF GLYCOGEN AND OLIGOSACCHARIDE CONTENTS IN ASCITES TUMOR CELLS BY ACTION OF NITROGEN MUSTRARD | |
| SUZUKI | BIOCHEMICAL STUDIES ON CARBOHYDRATES | |
| CN121574278A (zh) | 一种来源于紫杉状海门冬的卡拉胶类多糖atsp-1及其应用 | |
| KR20000016714A (ko) | 식물성 추출물, 그의 제조 방법 및 사람 및 수의용 의약에서의그의 응용 | |
| Gamgee et al. | On the nucleoproteids of the pancreas, thymus, and suprarenal gland, with especial reference to their optical activity |